Table 1.
Characteristics | All patients (n=221) | MSM (n=107) | HSM (n=40) | Women (n=74) | P-value |
---|---|---|---|---|---|
Age (median, IQR) | 50 (42–56) | 49 (41–57) | 55 (49–60) | 49 (42–53) | 0.0006 |
AIDS diagnosis (%) | 129 (58%) | 65 (61%) | 25 (63%) | 39 (53%) | 0.6 |
Viral load undetectable (<75 copies/mL) | 188 (85%) | 95 (89%) | 34 (85%) | 59 (80%) | 0.24 |
CD4 count (median, IQR) | 449 (302–634) | 452 (324–602) | 418 (283–596) | 470 (277–676) | 0.83 |
CD4 count <200 | 26 (12%) | 13 (12%) | 3 (8%) | 10 (14%) | 0.67 |
Current ART | 208 (94%) | 103 (96%) | 40 (100%) | 65 (88%) | 0.01 |
Smoking currently | 112 (51%) | 54 (50%) | 26 (65%) | 32 (43%) | 0.08 |
IVDU history | 35 (16%) | 3 (3%) | 18 (45%) | 14 (19%) | 0 |
Race | |||||
White | 114 (51%) | 86 (81%) | 14 (35%) | 14 (19%) | |
Black | 30 (14%) | 5 (4%) | 8 (20%) | 17 (23%) | |
Hispanic | 44 (20%) | 9 (8%) | 11 (28%) | 24 (32%) | |
American Indian | 2 (1%) | 0 | 1 (2%) | 1 (2%) | |
Asian | 3 (1%) | 3 (3%) | 0 | 0 | |
Unknown | 28 (13%) | 4 (4%) | 6 (15%) | 18 (24%) | |
Cervical HPV+ at any visit | 20 (31%)* | ||||
Cervical cytology+ at any visit | 30 (47%)* | ||||
Cervical HPV and cytology+ | 17 (27%)* |
Notes:
Denominator is 64.
Abbreviations: AIDS, acquired immunodeficiency syndrome; ART, antiretroviral therapy; HIV, human immunodeficiency virus; HPV, human papillomavirus; HSM, heterosexual men; IVDU, intravenous drug use; IQR, interquartile range; MSM, men who have sex with men.